1620 Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
1620 Investment Advisors, Inc.
- $122 Million
- Q2 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 10,781 shares of BMY stock, worth $573,441. This represents 0.37% of its overall portfolio holdings.
Number of Shares
10,781
Previous 17,174
37.22%
Holding current value
$573,441
Previous $931,000
51.99%
% of portfolio
0.37%
Previous 0.93%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...